Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.675 USD | +2.49% | -20.59% | +16.38% |
09/05 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.38% | 319M | |
+7.18% | 111B | |
+10.13% | 106B | |
-12.25% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.33% | 16.81B | |
+38.12% | 12.54B | |
-24.88% | 8.09B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Guggenheim Upgrades Mersana Therapeutics to Buy From Neutral, Price Target is $7